WO2009004141A2 - Method for preparing enantiomerically enriched n-carboxyanhydride - Google Patents
Method for preparing enantiomerically enriched n-carboxyanhydride Download PDFInfo
- Publication number
- WO2009004141A2 WO2009004141A2 PCT/FR2008/000703 FR2008000703W WO2009004141A2 WO 2009004141 A2 WO2009004141 A2 WO 2009004141A2 FR 2008000703 W FR2008000703 W FR 2008000703W WO 2009004141 A2 WO2009004141 A2 WO 2009004141A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carboxyanhydride
- formula
- alkyl
- methyl
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CN([C@@](*)C(O)=O)C(OC)=O Chemical compound CN([C@@](*)C(O)=O)C(OC)=O 0.000 description 2
- LMUVIOBZBRHXMY-BYPYZUCNSA-N C[C@@H](C(O)=O)N(C)C(OC)=O Chemical compound C[C@@H](C(O)=O)N(C)C(OC)=O LMUVIOBZBRHXMY-BYPYZUCNSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
Definitions
- the present application relates to a process for the preparation of an enantiomerically enriched ⁇ / -carboxyanhydride with an alpha amino acid, more particularly (L) - carboxyanhydride or (DJ-ZV-methylalanine). also relating to a chemical intermediate which is used in the preparation of the carboxyanhydride of (L) - or (OJ-W-methylalanine.
- Amino acid ⁇ -carboxyanhydrides are acylating agents which have the advantage of not forming annoying by-products in acylation reactions. When they are enantiomerically enriched, they also allow to introduce a chiral carbon. They are therefore chemical compounds useful in organic syntheses, in particular in the case of syntheses of pharmaceutical compounds which are often syntheses with several reaction stages. However, it is necessary that these compounds have sufficient purity, in particular enantiomeric purity. The industrial process of preparation must be simpler and have a good overall performance.
- the Applicant has developed a simple process for the preparation of ⁇ / -carboxyanhydride of alpha amino acid having a good overall yield and allowing access to a pure and enantiomerically enriched products. This process is more particularly applicable to carboxyanhydride of (L) - or (DJ- ⁇ / -methyl alanine.
- Alkyl group a linear or branched saturated aliphatic hydrocarbon group. By way of examples, mention may be made of methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl groups. It is preferably a (C 1 -C 4 ) group;
- Cycloalkyl group a cyclic alkyl group comprising between 3 and 8 carbon atoms, all the carbon atoms being involved in the cyclic structure.
- Aryl group an aromatic group comprising from 6 to 10 members, for example a phenyl group.
- the present invention relates to a process for preparing an enantiomerically enriched ⁇ / -carboxyanhydride of an alpha amino acid of formula (IMa):
- R1 and R2 denote, independently of one another, an alkyl group (eg methyl, ethyl, isopropyl), alkenyl (eg allyl), cycloalkyl, -alkyl-cycloalkyl (eg -CH 2 -cyclohexyl), -alkyl-aryl (eg benzyl), aryl;
- alkyl group eg methyl, ethyl, isopropyl
- alkenyl eg allyl
- cycloalkyl eg -alkyl-cycloalkyl (eg -CH 2 -cyclohexyl)
- -alkyl-aryl eg benzyl
- aryl eg benzyl
- R 3 denotes an alkyl group (eg methyl, ethyl, tert-butyl) or -alkyl-aryl (eg benzyl); comprising the following steps:
- step (ii) precipitating the ⁇ -carboxyanhydride formed in step (i) with a nonsolvent; (iii) recovering ⁇ / -carboxyanhydride.
- This process does not include any recrystallization step or sublimation of the N-carboxyanhydride.
- R 3 denotes a methyl or ethyl group, even more preferably methyl because at the end of step (i), a light compound (R 3 Cl) is formed which can be easily removed.
- R 1 and R 2 denote, independently of one another, a methyl or ethyl group. More preferably, R 1 and R 2 are both methyl and the ⁇ -carboxyanhydride of the following formula (A) (or (B)) is obtained:
- the solvent of step (i) may be a chlorinated solvent such as dichloromethane, an alkyl or aryl ether such as, for example, tetrahydrofuran, 2-methyl tetrahydrofuran or 1,4-dioxane, a aromatic solvent such as for example toluene, xylene, trifluoromethylbenzene, a ketone such as for example acetone, methyl isobutyl ketone, methyl ethyl ketone. A mixture of two or more of these solvents can also be used.
- a chlorinated solvent such as dichloromethane
- an alkyl or aryl ether such as, for example, tetrahydrofuran, 2-methyl tetrahydrofuran or 1,4-dioxane
- aromatic solvent such as for example toluene, xylene, trifluoromethylbenzene
- a ketone such as for example acetone, methyl is
- the reaction is conducted at a temperature between -10 and 5O 0 C, preferably between 0 C and 3O 0 1 even more preferably between 20 and 30 ° C.
- the reaction time is generally between 30 and 60 min.
- Precipitation of the ⁇ -carboxyanhydride formed in step (i) is carried out using a non-solvent.
- a liquid alkane n-heptane or octane
- a petroleum fraction petroleum ether, for example
- the N-carboxyanhydride can first be concentrated by removing a portion of the solvent from the reaction of step (i).
- ⁇ / -carboxyanhydride can be recovered simply by filtration / drying. This is one of the advantages of the process of the invention not to require a recrystallization step or sublimation to obtain sufficient purity and good performance.
- the advantage of using a liquid alkane in step (ii) is to be able to dry the ⁇ -carboxyanhydride easily.
- the compound of formula (IIa) (or (Mb)) may be prepared according to the following reaction (optionally during a step preceding step (i)):
- the base may be for example a carbonate, a bicarbonate or an alkali metal hydroxide.
- a preferred base is NaOH.
- This reaction can be carried out in a solvent which can be for example water or one of the solvents mentioned above.
- the reaction is conducted at a temperature of between 0 and 5 ° C.
- the duration of the reaction is generally between 5 and 6 hours.
- a CICO 2 R 3 / (IIa) molar ratio (or (Hb)> 1.9 is used.
- a base / (IIa) (or (Nb)> 2 molar ratio is also used.
- the method of the present invention makes it possible to obtain (whether the process includes the reaction preceding step (i) or not) a ⁇ / -carboxyanhydride in a simple manner, with a good yield (> at the yield disclosed in Journal of Chemical Society 1950) and good purity. In particular, it does not require any recrystallization or sublimation step.
- the cyclization of step (i) preserves the integrity of the asymmetric center and makes it possible to obtain an enantiomerically enriched product (no epimerization).
- the temperature of the reaction medium is raised to about 20 ° C by removing the ice / water bath, and the pH of the reaction medium is brought to about 1 (measured with a pH paper) to using 37% aqueous HCl.
- This aqueous phase is then extracted with 3 times 50 ml of AcOEt.
- the organic phases are combined, washed with 50 ml of demineralised water and then dried over approximately 10 g of anhydrous MgSO 4 .
- the medium is filtered on sintered glass, then the filtrate is concentrated to dryness in vacuo (bath temperature at about 35 ° C., vacuum of about 40 mbar). 13.4 g (86%) of product are thus obtained in the form of a colorless viscous oil.
- Chiral column gas chromatography analysis shows that the enantiomeric excess of the methyl carbamate of ⁇ -methyl alanine is> 99%.
- the conditions of the chromatographic analysis are given below: RT-Gammadex column (30 m / 0.25 mm / 0.25 ⁇ m); isothermal 120 ° C. (3 min), then 5 ° C./min at 180 ° C., isothermal at 18 ° C. (3 min); split injection 1: 25; helium carrier gas at 1.8 ml / min; FID detection; 2 mg / ml solution in CH 2 Cl 2 , esterification with 0.2 M TMSH.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
PROCEDE DE PREPARATION DE Λ/-CARBOXYAN HYDRI DE ENANTIOMERIQUEMENT ENRICHI PROCESS FOR PREPARING Λ / -CARBOXYAN HYDRI OF ENANTIOMERICALLY ENRICHED
La présente demande est relative à un procédé de préparation d'un Λ/-carboxyanhydride énantiomériquement enrichi d'un alpha acide aminé, plus particulièrement du carboxyanhydride de la (L)- ou de la (DJ-ZV-méthyl alanine. La demande est aussi relative à un intermédiaire chimique qui est utilisé dans la préparation du carboxyanhydride de la (L)- ou de la (OJ-W-méthyl alanine.The present application relates to a process for the preparation of an enantiomerically enriched Λ / -carboxyanhydride with an alpha amino acid, more particularly (L) - carboxyanhydride or (DJ-ZV-methylalanine). also relating to a chemical intermediate which is used in the preparation of the carboxyanhydride of (L) - or (OJ-W-methylalanine.
[Le domaine technique et le problème technique][The technical field and the technical problem]
Les Λ/-carboxyanhydrides d'acides d'aminés sont des agents acylants qui présentent l'avantage de ne pas former de sous-produits gênants dans les réactions d'acylation. Lorsqu'ils sont énantiomériquement enrichis, ils permettent de plus d'introduire un carbone chiral. Il s'agit donc de composés chimiques utiles dans les synthèses organiques, en particulier dans le cas des synthèses de composés pharmaceutiques qui sont souvent des synthèses à plusieurs étapes réactionnelles. Cependant, il est nécessaire que ces composés présentent une pureté suffisante, en particulier une pureté énantiomérique. Le procédé industriel de préparation doit être de plus simple et présenter un bon rendement global.Amino acid β-carboxyanhydrides are acylating agents which have the advantage of not forming annoying by-products in acylation reactions. When they are enantiomerically enriched, they also allow to introduce a chiral carbon. They are therefore chemical compounds useful in organic syntheses, in particular in the case of syntheses of pharmaceutical compounds which are often syntheses with several reaction stages. However, it is necessary that these compounds have sufficient purity, in particular enantiomeric purity. The industrial process of preparation must be simpler and have a good overall performance.
La Demanderesse a mis au point un procédé simple de préparation de Λ/-carboxyanhydride d'alpha acide aminé présentant un bon rendement global et permettant d'accéder à un produits pur et énantiomériquement enrichi. Ce procédé s'applique plus particulièrement au carboxyanhydride de la (L)- ou de la (DJ-Λ/-méthyl alanine.The Applicant has developed a simple process for the preparation of α / -carboxyanhydride of alpha amino acid having a good overall yield and allowing access to a pure and enantiomerically enriched products. This process is more particularly applicable to carboxyanhydride of (L) - or (DJ-Λ / -methyl alanine.
[L'art antérieur][The prior art]
Dans Tetrahedron 1994, 50, N°18, 5309-5322, la préparation de Λ/-carboxyanhydrides protégés sur l'atome d'azote par RO-C(=O)- à partir de Λ/,Λ/-bis-alcoxycarbonyl)amino acides et du réactif de Vilsmeier-Haack SOCI2/DMF.In Tetrahedron 1994, 50, No. 18, 5309-5322, the preparation of protégés / -carboxyanhydrides protected on the nitrogen atom by RO-C (= O) - from Λ /, Λ / -bis-alkoxycarbonyl ) amino acids and Vilsmeier-Haack SOCI 2 / DMF reagent.
Dans l'article « Untersuchungen ϋber Alpha-amino-N-carbonàureanhydride. I » de Zeitschrift fur Physiologische Chemie », Walter de Bruyter, Berlin 1925, 46, 72-90, la préparation de N- carboxyanhyd rides est décrite mais sans aucune étape de purification.In the article "Untersuchungen ϋber Alpha-amino-N-carbonureanhydride. I, Zeitschrift fur Physiologische Chemie, Walter de Bruyter, Berlin 1925, 46, 72-90, the preparation of N-carboxyanhydrides is described but without any purification step.
Dans Angew. Chem. Int. Ed. 2003, 42, 5348-5351 , la préparation de Λ/-carboxyanhydrides protégés sur l'atome d'azote par RO-C(=O)- est décrite sur le Schéma 3 faisant référence à Tetrahedron Letters 1996, 37, 8439 mais aucune étape de purification n'est décrite.In Angew. Chem. Int. Ed. 2003, 42, 5348-5351, the preparation of protégés / -carboxyanhydrides protected on the nitrogen atom by RO-C (= O) - is described in Scheme 3 referring to Tetrahedron Letters 1996, 37, 8439 but no purification step is described.
Dans J. Org. Chem. 1994, 59, 2437-2446, la préparation de Λ/-carboxyanhydrides est décrite mais utilisant une autre réaction chimique. Dans Tetrahedron 1994, 50, 30, 9051-9060, la préparation de Λ/-carboxyanhydrides à partir d'acides aminés protégés par tBuO-C(=O)- (BOC) et de PCI3 est décrite. L'emploi de PCI3 conduit à la formation de sous-produits phosphores qui restent combinés au N- carboxyanhydride et qu'il est nécessaire d'éliminer par une étape de lavage avec un solvant perchloré non acceptable industriellement (CCI4).In J. Org. Chem. 1994, 59, 2437-2446, the preparation of Λ / -carboxyanhydrides is described but using another chemical reaction. In Tetrahedron 1994, 50, 30, 9051-9060, the preparation of Λ / -carboxyanhydrides from amino acids protected by tBuO-C (= O) - (BOC) and PCI 3 is described. The use of PCI 3 leads to the formation of phosphorus byproducts which remain combined with N-carboxyanhydride and which must be removed by a washing step with an industrially unacceptable perchlorinated solvent (CCI 4 ).
Dans Journal of Chemical Society 1950, 3009-3013, la préparation de Λ/-carboxyanhydrides est conduite à partir d'un mélange des deux acides aminés (D et L) protégés par MeO- C(=O)- et de SOCI2 et non à partir de l'acide aminé D ou bien L. De plus, le produit final est obtenu après une étape de précipitation, une étape de recristallisation et une étape de sublimation. Le rendement pondéral calculé est de 39% uniquement.In Journal of Chemical Society 1950, 3009-3013, the preparation of Λ / -carboxyanhydrides is conducted from a mixture of the two amino acids (D and L) protected by MeO-C (= O) - and SOCI 2 and not from amino acid D or L. In addition, the final product is obtained after a precipitation step, a recrystallization step and a sublimation step. The calculated weight yield is 39% only.
Dans J. Mar. Chim. Heterocycl. 2002, 1, 44-47, la préparation de N-carboxyanhydrides est conduite à partir d'acide aminé protégé et de POCI3.In J. Mar. Chim. Heterocycl. 2002, 1, 44-47, the preparation of N-carboxyanhydrides is conducted from protected amino acid and POCI 3 .
Aucun de ces documents ne décrit ni ne suggère le procédé de l'invention.None of these documents describes or suggests the method of the invention.
[Description de l'invention][Description of the invention]
définitions utiliséesdefinitions used
• groupe alkyle : un groupe hydrocarboné aliphatique saturé linéaire ou ramifié. A titre d'exemples, on peut citer les groupes méthyle, éthyle, propyle, isopropyle, butyle, iso- butyle, tertio-butyle. Il s'agit de préférence d'un groupe (C1-C4) ;Alkyl group: a linear or branched saturated aliphatic hydrocarbon group. By way of examples, mention may be made of methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl groups. It is preferably a (C 1 -C 4 ) group;
• groupe alkényle : un groupe alkyle comprenant une double liaison C=C ;Alkenyl group: an alkyl group comprising a C = C double bond;
• groupe cycloalkyle : un groupe alkyle cyclique comprenant entre 3 et 8 atomes de carbone, tous les atomes de carbone étant engagés dans la structure cyclique. A titre d'exemples, on peut citer les groupes cyclopropyle, cyclobutyle, cyclopentyle, cyclohexyle ;Cycloalkyl group: a cyclic alkyl group comprising between 3 and 8 carbon atoms, all the carbon atoms being involved in the cyclic structure. By way of examples, mention may be made of cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl groups;
• groupe aryle : un groupe aromatique comprenant de 6 à 10 chaînons, par exemple un groupe phényle.Aryl group: an aromatic group comprising from 6 to 10 members, for example a phenyl group.
La présente invention est relative à un procédé de préparation d'un Λ/-carboxyanhydride énantiomériquement enrichi d'un alpha acide aminé de formule (IMa) :The present invention relates to a process for preparing an enantiomerically enriched Λ / -carboxyanhydride of an alpha amino acid of formula (IMa):
(NIa) à partir du composé de formule (lia) : (NIa) from the compound of formula (IIa):
(lia) formules dans lesquelles :(IIa) formulas in which:
• R1 et R2 désignent, indépendamment l'un de l'autre, un groupe alkyle (par ex. méthyle, éthyle, isopropyle), alkényle (par ex. allyle), cycloalkyle, -alkyle-cycloalkyle (par ex. -CH2-cyclohexyle), -alkyle-aryle (par ex. benzyle), aryle ;R1 and R2 denote, independently of one another, an alkyl group (eg methyl, ethyl, isopropyl), alkenyl (eg allyl), cycloalkyl, -alkyl-cycloalkyl (eg -CH 2 -cyclohexyl), -alkyl-aryl (eg benzyl), aryl;
• R3 désigne un groupe alkyle (par ex. méthyle, éthyle, tertio-butyle) ou -alkyle-aryle (par ex. benzyle) ; comprenant les étapes suivantes :R 3 denotes an alkyl group (eg methyl, ethyl, tert-butyl) or -alkyl-aryl (eg benzyl); comprising the following steps:
(i) mettre en contact le composé de formule (lia) (ou respectivement (Mb)) avec(i) contacting the compound of formula (IIa) (or respectively (Mb)) with
SOCI2 dans un solvant ;SOCI 2 in a solvent;
(ii) précipiter le Λ/-carboxyanhydride formé à l'étape (i) à l'aide d'un non-solvant ; (iii) récupérer le Λ/-carboxyanhydride.(ii) precipitating the Λ-carboxyanhydride formed in step (i) with a nonsolvent; (iii) recovering Λ / -carboxyanhydride.
Ce procédé ne comprend aucune étape de recristallisation, ni de sublimation du N- carboxyanhydride.This process does not include any recrystallization step or sublimation of the N-carboxyanhydride.
Ce procédé s'applique de façon similaire au composé (MIb) à partir du composé (Mb) :This method is applied in a similar way to the compound (MIb) from the compound (Mb):
(IMb) (Mb)(IMb) (Mb)
De préférence, R3 désigne un groupe méthyle ou éthyle, encore plus préférentiellement méthyle car à l'issue de l'étape (i), il se forme alors un composé léger (R3CI) qui peut être éliminé facilement.Preferably, R 3 denotes a methyl or ethyl group, even more preferably methyl because at the end of step (i), a light compound (R 3 Cl) is formed which can be easily removed.
De préférence, R1 et R2 désignent, indépendamment l'un de l'autre, un groupe méthyle ou éthyle. Plus préférentiellement, R1 et R2 désignent tous deux un groupe méthyle et l'on obtient le Λ/-carboxyanhydride de formule (A) (ou (B)) suivant :Preferably, R 1 and R 2 denote, independently of one another, a methyl or ethyl group. More preferably, R 1 and R 2 are both methyl and the β-carboxyanhydride of the following formula (A) (or (B)) is obtained:
(A) (B) (A) est le Λ/-carboxyanhydride de la (L)-Λ/-méthyl-alanine. On utilise de préférence le composé (Ma) de formule :(A) (B) (A) is Λ-carboxyanhydride of (L) -Λ-methyl-alanine. The compound (Ma) of formula
qui est le carbamate de méthyle de la (/.)-Λ/-méthyl alanine. which is the methyl carbamate of (/.) - / - methyl alanine.
(B) le Λ/-carboxyanhydride de la (D)-Λ/-méthyl-alanine. On utilise de préférence le composé (Mb) qui est le carbamate de la (D)-N-méthyl alanine :(B) β-carboxyanhydride of (D) -β-methyl-alanine. The compound (Mb) which is the carbamate of (D) -N-methylalanine is preferably used:
Etape (i)Step (i)
Le solvant de l'étape (i) peut-être un solvant chloré tel que le dichlorométhane, un éther d'alkyle ou d'aryle tel que par exemple le tétrahydrofurane, le 2-méthyl tétrahydrofurane, le 1 ,4-dioxanne, un solvant aromatique tel que par exemple le toluène, un xylène, le trifluorométhylbenzène, une cétone telle que par exemple l'acétone, la méthylisobutyl cétone, la méthyléthyl cétone. On peut utiliser également un mélange de deux ou plusieurs de ces solvants.The solvent of step (i) may be a chlorinated solvent such as dichloromethane, an alkyl or aryl ether such as, for example, tetrahydrofuran, 2-methyl tetrahydrofuran or 1,4-dioxane, a aromatic solvent such as for example toluene, xylene, trifluoromethylbenzene, a ketone such as for example acetone, methyl isobutyl ketone, methyl ethyl ketone. A mixture of two or more of these solvents can also be used.
On utilise généralement entre 1 et 3 équivalent(s) de SOCI2 par rapport au composé (lia) (ou (Hb)).1 to 3 equivalents of SOCI 2 are generally used relative to the compound (IIa) (or (Hb)).
La réaction est conduite à une température comprise entre -10 et 5O0C, de préférence entre 0 et 3O0C1 encore plus préférentiellement entre 20 et 30°C. La durée de la réaction est comprise généralement entre 30 et 60 min.The reaction is conducted at a temperature between -10 and 5O 0 C, preferably between 0 C and 3O 0 1 even more preferably between 20 and 30 ° C. The reaction time is generally between 30 and 60 min.
Etape (ii)Step (ii)
La précipitation du Λ/-carboxyanhydride formé à l'étape (i) est conduite à l'aide d'un non- solvant. On utilise avantageusement un alcane liquide (n-heptane ou octane par ex.) ou bien une coupe pétrolière (éther de pétrole par ex.). On peut au préalable concentrer le N- carboxyanhydride en éliminant une partie du solvant de la réaction de l'étape (i).Precipitation of the β-carboxyanhydride formed in step (i) is carried out using a non-solvent. Advantageously, a liquid alkane (n-heptane or octane) or a petroleum fraction (petroleum ether, for example) is used. The N-carboxyanhydride can first be concentrated by removing a portion of the solvent from the reaction of step (i).
On peut utiliser comme couple solvant/non-solvant, un solvant chloré et un alcane liquide ou une coupe pétrolière, notamment le couple dichlorométhane/n-heptane décrit dans l'exemple 2. Etape (iii)It is possible to use a solvent / non-solvent pair, a chlorinated solvent and a liquid alkane or a petroleum cut, in particular the dichloromethane / n-heptane couple described in Example 2. Step (iii)
Le Λ/-carboxyanhydride peut être récupéré simplement par filtration/séchage. C'est là l'un des avantages du procédé de l'invention de ne pas nécessiter d'étape de recristallisation ou de sublimation pour obtenir une pureté suffisante et un bon rendement. L'avantage à utiliser un alcane liquide à l'étape (ii) est de pouvoir sécher facilement le Λ/-carboxyanhydride.Λ / -carboxyanhydride can be recovered simply by filtration / drying. This is one of the advantages of the process of the invention not to require a recrystallization step or sublimation to obtain sufficient purity and good performance. The advantage of using a liquid alkane in step (ii) is to be able to dry the Λ-carboxyanhydride easily.
Préparation du composé de formule (Ha) ou (Ub)Preparation of the compound of formula (Ha) or (Ub)
Le composé de formule (lia) (ou (Mb)) peut être préparé selon la réaction suivante (éventuellement au cours d'une étape précédant l'étape (i)):The compound of formula (IIa) (or (Mb)) may be prepared according to the following reaction (optionally during a step preceding step (i)):
(ou bien respectiveme nt selon ) en présence d'une base. La base peut être par exemple un carbonate, un bicarbonate ou un hydroxyde d'un métal alcalin. Une base préférée est NaOH.(or else according to) in the presence of a base. The base may be for example a carbonate, a bicarbonate or an alkali metal hydroxide. A preferred base is NaOH.
Cette réaction peut être conduite dans un solvant qui peut être par exemple l'eau ou l'un des solvants cités précédemment. La réaction est conduite à une température comprise entre O et 5°C. La durée de la réaction est comprise généralement entre 5 et 6 heures. De préférence, on utilise un rapport molaire CICO2R3/(lla) (ou (Hb) > 1,9. De préférence aussi, on utilise un rapport molaire base/(lla) (ou (Nb) > 2.This reaction can be carried out in a solvent which can be for example water or one of the solvents mentioned above. The reaction is conducted at a temperature of between 0 and 5 ° C. The duration of the reaction is generally between 5 and 6 hours. Preferably, a CICO 2 R 3 / (IIa) molar ratio (or (Hb)> 1.9 is used.) Preferably, a base / (IIa) (or (Nb)> 2 molar ratio is also used.
Le procédé de la présente invention permet d'obtenir (que le procédé inclue la réaction précédant l'étape (i) ou non) un Λ/-carboxyanhydride de façon simple, avec un bon rendement (> au rendement divulgué dans Journal of Chemical Society 1950) et une bonne pureté. En particulier, il ne nécessite aucune étape de recristallisation ni de sublimation. La cyclisation de l'étape (i) préserve l'intégrité du centre asymétrique et permet d'obtenir un produit énantiomériquement enrichi (aucune épimérisation).The method of the present invention makes it possible to obtain (whether the process includes the reaction preceding step (i) or not) a Λ / -carboxyanhydride in a simple manner, with a good yield (> at the yield disclosed in Journal of Chemical Society 1950) and good purity. In particular, it does not require any recrystallization or sublimation step. The cyclization of step (i) preserves the integrity of the asymmetric center and makes it possible to obtain an enantiomerically enriched product (no epimerization).
[Exemples][Examples]
L'homme du métier pourra s'inspirer avantageusement des conditions divulguées dans les deux exemples qui suivent. Ex 1 : Préparation de l'acide (S)-2-(méthoxycarbonyl-méthyl-amino)-propionique)Those skilled in the art will be able to draw advantageously from the conditions disclosed in the two examples which follow. Ex 1: Preparation of (S) -2- (methoxycarbonyl-methyl-amino) -propionic acid)
Dans un bicol de 250 ml sous atmosphère d'azote sont chargés successivement : 10 gr (97 mmoles) de (L)-Λ/-méthyl alanine, puis 200 ml d'une solution aqueuse 1 M de NaOH (200 mmoles, 2,06 éq.). La suspension blanche ainsi obtenue est agitée jusqu'à complète dissolution (environ 30 minutes). Cette solution est refroidie à environ 3°C à l'aide d'un bain eau/glace, et sous une vigoureuse agitation (environ 750 tours/min), 15 ml de chloroformiate de méthyle (192 mmoles, 1 ,98 éq.) sont ajoutés en 30 minutes environ à l'aide d'une ampoule de coulée de 50 ml. Le milieu biphasique ainsi obtenu est agité à 30C.In a bicolor of 250 ml under nitrogen atmosphere are successively charged: 10 gr (97 mmol) of (L) -Λ-methyl-alanine, then 200 ml of a 1 M aqueous solution of NaOH (200 mmol, 2, 06 eq.). The white suspension thus obtained is stirred until complete dissolution (approximately 30 minutes). This solution is cooled to about 3 ° C. using a water / ice bath, and under vigorous stirring (about 750 rpm), 15 ml of methyl chloroformate (192 mmol, 1.98 eq.) are added in about 30 minutes using a 50 ml dropping funnel. The biphasic medium thus obtained is stirred at 30.degree .
Au bout de 6 heures, la température du milieu réactionnel est remontée à environ 20°C en retirant le bain glace/eau, et le pH du milieu réactionnel est amené à environ 1 (mesuré à l'aide d'un papier pH) à l'aide d'HCI aqueux à 37%. Cette phase aqueuse est alors extraite par 3 fois 50 ml d'AcOEt. Les phases organiques sont réunies, lavées par 50 ml d'eau déminéralisée, puis séchées sur environ 10 gr de MgSO4 anhydre. Le milieu est filtré sur verre fritte, puis le filtrat est concentré à sec sous vide (température du bain à environ 35° C, vide d'environ 40 mbars). On obtient ainsi 13,4 gr (86%) de produit sous forme d'une huile visqueuse incolore.After 6 hours, the temperature of the reaction medium is raised to about 20 ° C by removing the ice / water bath, and the pH of the reaction medium is brought to about 1 (measured with a pH paper) to using 37% aqueous HCl. This aqueous phase is then extracted with 3 times 50 ml of AcOEt. The organic phases are combined, washed with 50 ml of demineralised water and then dried over approximately 10 g of anhydrous MgSO 4 . The medium is filtered on sintered glass, then the filtrate is concentrated to dryness in vacuo (bath temperature at about 35 ° C., vacuum of about 40 mbar). 13.4 g (86%) of product are thus obtained in the form of a colorless viscous oil.
analyses structurales : LC-MS-DAD-ELSD : 160(-)=(M-H)(-), 162(+)=(M+H)(+) ; RMN 1H (DMSO d6 à 400 MHz) : pour ce lot, un mélange 60-40% de conformères est observé, avec : 1 ,31 (d, J = 7,5 Hz, 3H) ; 2,78 (s, 3H) ; 3,58 (s, 1 ,2H) ; 3,60 (s, 1 ,8H) ; 4,50 (qr, J = 7,5 Hz, 0,4H) ; 4,58 (q, J = 7,5 Hz, 0,6H) ; 10,7 (m étalé, 1H).structural analyzes: LC-MS-DAD-ELSD: 160 (-) = (MH) (-), 162 (+) = (M + H) (+); 1 H NMR (DMSO d 6 at 400 MHz): for this batch, a 60-40% mixture of conformers is observed, with: 1.31 (d, J = 7.5 Hz, 3H); 2.78 (s, 3H); 3.58 (s, 1, 2H); 3.60 (s, 1, 8H); 4.50 (qr, J = 7.5 Hz, 0.4H); 4.58 (q, J = 7.5 Hz, 0.6H); 10.7 (spread m, 1H).
Une analyse par chromatographie gaz sur colonne chirale permet de montrer que l'excès énantiomèrique du carbamate de méthyle de la Λ/-méthyl alanine est >99%. Les conditions de l'analyse chromatographique sont données ci-après : colonne RT-Gammadex (30 m / 0,25 mm / 0,25 μm) ; isotherme 1200C (3 min), puis 5°C/min à 1800C, isotherme à 18O0C (3 min) ; injection split 1 :25 ; gaz vecteur hélium à 1 ,8 ml/min ; détection FID ; solution à 2 mg/ml dans CH2CI2, estérification avec TMSH 0,2 M. Dans ces conditions, le carbamate de méthyle de la (L)-Λ/-méthyl alanine a un temps de rétention tr = 8,8 min. L'autre énantiomère, le carbamate de méthyle de la (D)-Λ/-méthyl alanine présente un temps de rétention tr = 8,5 min. Ex 2 : Préparation de (S)-3,4-diméthyl-1,3-oxazolidine-2,5-dione)Chiral column gas chromatography analysis shows that the enantiomeric excess of the methyl carbamate of Λ-methyl alanine is> 99%. The conditions of the chromatographic analysis are given below: RT-Gammadex column (30 m / 0.25 mm / 0.25 μm); isothermal 120 ° C. (3 min), then 5 ° C./min at 180 ° C., isothermal at 18 ° C. (3 min); split injection 1: 25; helium carrier gas at 1.8 ml / min; FID detection; 2 mg / ml solution in CH 2 Cl 2 , esterification with 0.2 M TMSH. Under these conditions, the methyl carbamate of (L) -Λ-methyl-alanine has a retention time of tr = 8.8 min. . The other enantiomer, the methyl carbamate of (D) -Λ / -methyl alanine has a retention time tr = 8.5 min. Ex 2: Preparation of (S) -3,4-dimethyl-1,3-oxazolidine-2,5-dione
1 gr (6,2 mmoles) du produit obtenu précédemment est mis en solution dans 3 ml de CH2CI2, agité pendant 5 minutes à environ 200C, puis traité par SOCI2 (500 μl, 1 ,1 éq.). Le milieu réactionnel est alors chauffé à environ 30° C, et le chauffage est maintenu pendant environ 30 min. Le milieu réactionnel est alors concentré à environ 1 ,5 volume, et toujours sous agitation, 10 ml de n-heptane sont ajoutés. La masse blanche ainsi obtenue est alors refroidie à environ -20° C, et agitée pendant 1 heure à cette température. La suspension est alors filtrée sur verre fritte, le solide est lavé par 3 fois 3 ml de n-heptane. Après séchage à l'air pendant 2 heures, le produit (700 mg, 87,4%) est obtenu sous forme d'aiguilles blanches.1 g (6.2 mmol) of the product obtained above is dissolved in 3 ml of CH 2 Cl 2 , stirred for 5 minutes at approximately 20 0 C, then treated with SOCI 2 (500 μl, 1.1 eq.) . The reaction medium is then heated to about 30 ° C, and the heating is maintained for about 30 min. The reaction medium is then concentrated to about 1.5 volume, and still stirring, 10 ml of n-heptane are added. The white mass thus obtained is then cooled to about -20 ° C, and stirred for 1 hour at this temperature. The suspension is then filtered on sintered glass, the solid is washed with 3 times 3 ml of n-heptane. After drying in air for 2 hours, the product (700 mg, 87.4%) is obtained as white needles.
analyses structurales : RMN 1H (DMSO d6 à 400 MHz) : 1 ,39 (d, J = 7,5 Hz, 3H) ; 2,83 (s, 3H) ; 4,40 (g, J = 7,5 Hz, 1H).structural analyzes: 1 H NMR (DMSO d 6 at 400 MHz): 1.39 (d, J = 7.5 Hz, 3H); 2.83 (s, 3H); 4.40 (g, J = 7.5 Hz, 1H).
Une analyse par chromatographie gaz sur colonne chirale permet de montrer que l'excès énantiomérique de la (S)-3,4-diméthyl-1 ,3-oxazolidine-2,5-dione) est >99%, et qu'aucune épimérisation n'a eu lieu dans les conditions de cyclisation. Conditions de la chromatographie gaz : colonne RT-Gammadex (30 m / 0,25 mm / 0,25 μm) ; température initiale 180°C puis 5°C/min à 2200C, isotherme à 1800C pendant 5 min ; injection split 1 :25 ; gaz vecteur hélium à 1 ,8 ml/min ; détection FID ; solution à 2 mg/ml dans CH2CI2. Dans ces conditions, la (S)-3,4-diméthyl-1 ,3-oxazolidine-2,5-dione a un temps de rétention tr = 8,4 min. L'autre énantiomère, la (R)-3,4-diméthyl-1 ,3-oxazolidine-2,5-dione) a un temps de rétention tr = 8,7 min.Chiral column gas chromatography analysis shows that the enantiomeric excess of (S) -3,4-dimethyl-1,3-oxazolidine-2,5-dione) is> 99%, and no epimerization occurred under cyclization conditions. Conditions for gas chromatography: RT-Gammadex column (30 m / 0.25 mm / 0.25 μm); initial temperature 180 ° C then 5 ° C / min at 220 0 C, isothermal at 180 0 C for 5 min; split injection 1: 25; helium carrier gas at 1.8 ml / min; FID detection; 2 mg / ml solution in CH 2 Cl 2 . Under these conditions, (S) -3,4-dimethyl-1,3-oxazolidine-2,5-dione has a retention time of tr = 8.4 min. The other enantiomer, (R) -3,4-dimethyl-1,3-oxazolidine-2,5-dione) has a retention time of tr = 8.7 min.
Le rendement global calculé à partir de la (L)-Λ/-méthyl alanine de départ est donc de 86% x 87,4% soit 75%. Ce rendement est supérieur à celui obtenu dans Journal of Chemical Society 1950. The overall yield calculated from the starting (L) -Λ-methyl-alanine is therefore 86% x 87.4% or 75%. This yield is higher than that obtained in Journal of Chemical Society 1950.
Claims
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010508878A JP5485142B2 (en) | 2007-05-25 | 2008-05-22 | Process for the preparation of enantiomerically enriched N-carboxylic anhydrides |
| EP08805594.2A EP2152680B1 (en) | 2007-05-25 | 2008-05-22 | Method for preparing enantiomerically enriched n-carboxyanhydride |
| ES08805594.2T ES2547651T3 (en) | 2007-05-25 | 2008-05-22 | Preparation procedure of enantiomerically enriched N-carboxyanhydride |
| US12/617,398 US8119813B2 (en) | 2007-05-25 | 2009-11-12 | Method for preparing enantiomerically enriched N-carboxyanhydride |
| US13/399,337 US20120215007A1 (en) | 2007-05-25 | 2012-02-17 | Method for preparing enantiomerically enriched n-carboxyanhydride |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0703702 | 2007-05-25 | ||
| FR0703702A FR2916444B1 (en) | 2007-05-25 | 2007-05-25 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED N-CARBOXYANHYDRIDE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/617,398 Continuation US8119813B2 (en) | 2007-05-25 | 2009-11-12 | Method for preparing enantiomerically enriched N-carboxyanhydride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009004141A2 true WO2009004141A2 (en) | 2009-01-08 |
| WO2009004141A3 WO2009004141A3 (en) | 2009-04-09 |
Family
ID=38863061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2008/000703 Ceased WO2009004141A2 (en) | 2007-05-25 | 2008-05-22 | Method for preparing enantiomerically enriched n-carboxyanhydride |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8119813B2 (en) |
| EP (1) | EP2152680B1 (en) |
| JP (1) | JP5485142B2 (en) |
| AR (1) | AR066704A1 (en) |
| CL (1) | CL2008001512A1 (en) |
| ES (1) | ES2547651T3 (en) |
| FR (1) | FR2916444B1 (en) |
| PA (1) | PA8781401A1 (en) |
| PE (1) | PE20090719A1 (en) |
| TW (1) | TWI430996B (en) |
| UY (1) | UY31104A1 (en) |
| WO (1) | WO2009004141A2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1299341B1 (en) * | 1998-02-09 | 2000-03-16 | Pfc Italiana Srl | PROCESS FOR THE PRODUCTION OF INTERMEDIATE ALKOXY CARBONYL DIPEPTIDES IN THE SYNTHESIS OF LISINOPRIL. |
| FR2825705B1 (en) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | NOVEL HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-BACTERIANS |
-
2007
- 2007-05-25 FR FR0703702A patent/FR2916444B1/en active Active
-
2008
- 2008-05-21 TW TW097118694A patent/TWI430996B/en not_active IP Right Cessation
- 2008-05-22 ES ES08805594.2T patent/ES2547651T3/en active Active
- 2008-05-22 WO PCT/FR2008/000703 patent/WO2009004141A2/en not_active Ceased
- 2008-05-22 EP EP08805594.2A patent/EP2152680B1/en active Active
- 2008-05-22 JP JP2010508878A patent/JP5485142B2/en not_active Expired - Fee Related
- 2008-05-23 PA PA20088781401A patent/PA8781401A1/en unknown
- 2008-05-23 UY UY31104A patent/UY31104A1/en not_active Application Discontinuation
- 2008-05-23 PE PE2008000886A patent/PE20090719A1/en not_active Application Discontinuation
- 2008-05-23 AR ARP080102183A patent/AR066704A1/en unknown
- 2008-05-23 CL CL2008001512A patent/CL2008001512A1/en unknown
-
2009
- 2009-11-12 US US12/617,398 patent/US8119813B2/en active Active
-
2012
- 2012-02-17 US US13/399,337 patent/US20120215007A1/en not_active Abandoned
Non-Patent Citations (6)
| Title |
|---|
| AKSSIRA M ET AL: "New routes to 1,4-benzodiazepin-2,5-diones" TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 50, no. 30, 1994, pages 9051-9060, XP003009450 ISSN: 0040-4020 cité dans la demande * |
| COSTE JACQUES ET AL: "Coupling N-methylated amino acids using PyBroP-1 and PyCloP halogenophosphonium salts: Mechanism and fields of application" JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 59, no. 9, 1994, pages 2437-2466, XP002259799 ISSN: 0022-3263 * |
| HANBY W E ET AL: "Synthetic Polypeptides" JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL SOCIETY. LETCHWORTH, GB, 1950, pages 3009-3013, XP009094366 ISSN: 0368-1769 cité dans la demande * |
| JIDONG ZHU AND CO: "Total synthesis of Microsclerodermin E" ANGEW. CHEM. INT. ED., vol. 42, 2003, pages 5348-5351, XP002465215 * |
| SAVRDA J ET AL: "activation of N,N-bis(alkoxycarbonyl) amino acids. SYNTHESIS OF N-ALKOXYCARBONYL AMINO ACID N-CARBOXYANHYDRIDES AND N,N-DIALKOXYCARBONYL AMINO ACID FLUORIDES, AND THE BEHAVIOUR OF THESE AMINO ACID DERIVATIVES" TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 50, no. 18, 1994, pages 5309-5322, XP002287687 ISSN: 0040-4020 * |
| WESSELY F: "Untersuchungen ueber Alpha-Amino-N-Carbonsaeureanhydride. I" HOPPE-SEYLER'S ZEITSCHRIFT FUER PHYSIOLOGISCHE CHEMIE, WALTER DE GRUYTER, BERLIN, DE, vol. 146, 1925, pages 72-90, XP009094274 ISSN: 0018-4888 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PE20090719A1 (en) | 2009-07-13 |
| US20120215007A1 (en) | 2012-08-23 |
| TW200914432A (en) | 2009-04-01 |
| US20100113797A1 (en) | 2010-05-06 |
| JP2010527975A (en) | 2010-08-19 |
| FR2916444B1 (en) | 2011-02-11 |
| JP5485142B2 (en) | 2014-05-07 |
| EP2152680B1 (en) | 2015-06-24 |
| CL2008001512A1 (en) | 2009-09-25 |
| EP2152680A2 (en) | 2010-02-17 |
| TWI430996B (en) | 2014-03-21 |
| FR2916444A1 (en) | 2008-11-28 |
| PA8781401A1 (en) | 2008-12-18 |
| WO2009004141A3 (en) | 2009-04-09 |
| AR066704A1 (en) | 2009-09-09 |
| UY31104A1 (en) | 2009-01-05 |
| US8119813B2 (en) | 2012-02-21 |
| ES2547651T3 (en) | 2015-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0828702B1 (en) | Process for resolving chiral acids with 1-aminoindan-2-ols | |
| Aubé et al. | Oxaziridine-Mediated Ring Expansions of Substituted Cyclobutanones: Synthesis of (-)-γ-Amino-β-Hydroxybutyric Acid (GABOB) | |
| EP2102218A2 (en) | Method for preparing 1,3,2-oxazaborolidine compounds | |
| CN113816855A (en) | Method for synthesizing chiral allyl carboxylic ester | |
| EP4103544A1 (en) | Preparation of s-beflubutamid by resolving 2-(4-fluoro-3-(trifluoromethyl)phenoxy)butanoic acid | |
| FR2470758A1 (en) | METHOD FOR FIXING ALKYL GROUPS ON A CARBONIC CHAIN CARRYING A FUNCTIONAL GROUP | |
| EP2152680B1 (en) | Method for preparing enantiomerically enriched n-carboxyanhydride | |
| Enders et al. | Diastereo-and enantioselective synthesis of α, β-disubstituted γ-nitro methyl sulfonatesDedicated to Professor Helmut Zahn on the occasion of his 85th birthday. | |
| JP3855295B2 (en) | Method for producing bisoxazolines | |
| JP2012158599A (en) | Synthesis of pyrrole-2-carbonitrile | |
| FR2655039A1 (en) | SYNTHESIS OF PERFLUOROALKYL BROMIDES. | |
| AU2006294950A1 (en) | Process for the stereoselective preparation of (-)-halofenate and intermediates thereof | |
| FR2460951A1 (en) | PROCESS FOR THE PREPARATION OF 15-HYDROXYIMINO-E-HOMOEBURNANE DERIVATIVES AND COMPOUNDS OBTAINED THEREBY | |
| EP0301925B1 (en) | Process for the enantiospecific preparation of (s)2-ethyl amino-1-3-(trifluoromethyl phenyl) propane | |
| FR2779722A1 (en) | Preparation of 1,5-dialkyl-6- methyl aryl uracil derivatives with improved purity | |
| WO2018193463A1 (en) | An improved process for the preparation of tetrahydroisoquinoline compounds | |
| JP4218310B2 (en) | Process for producing optically active 2-amino-2-phenylethanol and its intermediate | |
| JPH0710822A (en) | Separation of optical isomer of amino acid ester | |
| FR2642204A1 (en) | ||
| SU795473A3 (en) | Method of preparing n-substituted n-2-(2-furylethyl)amines or their salts | |
| JP2831776B2 (en) | Isomer separation method | |
| SK288218B6 (en) | Process for the preparation of 1-nitro-4-oxobutanylamides and opposite enantiomers thereof | |
| FR2855175A1 (en) | Production of indium carboxylate or carboxylate-halide for use e.g. as Lewis acid co-catalyst, involves reacting indium halide with alkali metal or ammonium carboxylate in anhydrous polar aprotic solvent | |
| JPH06293733A (en) | N-cinnamoylproline derivative as new optically resolving agent and its alkali salt | |
| JPH0267237A (en) | Method for producing optically active 1,1,1-trifluoro-2-alkanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08805594 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2008805594 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010508878 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |